Treatment effects of gabapentin for primary insomnia

Clinical Neuropharmacology

Volumn 33, Issue 2, 2010, Pages 84-90

  Lo, Hsiao Sui ^a   Yang, Chien Ming ^b   Lo, Helen G ^c   Lee, Chien Ying ^d,e   Ting, Hua ^f   Tzang, Bor Show ^d  

^a University Hospital   (South Korea)

^b NATIONAL CHENGCHI UNIVERSITY   (Taiwan)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^d CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^e Department of Pharmacy   (South Korea)

^f Department of Rehabilitation and Sleep Center ^*  (Taiwan)

Author keywords

EEG spectral analysis; Gabapentin; Heart rate variability; Insomnia; Polysomnography

Indexed keywords

GABAPENTIN; PROLACTIN;

ARTICLE; BLOOD TESTIS BARRIER; CLINICAL ARTICLE; DELTA RHYTHM; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFECT; DRUG MECHANISM; EVENING DOSAGE; FEMALE; HEART RATE VARIABILITY; HUMAN; INSOMNIA; MALE; NEUROPSYCHOLOGICAL TEST; POLYSOMNOGRAPHY; PRIMARY INSOMNIA; PRIORITY JOURNAL; SLEEP STAGE; SOMNOLENCE; THETA RHYTHM; VISUOMOTOR COORDINATION;

ADULT; AMINES; BLOOD CHEMICAL ANALYSIS; CYCLOHEXANECARBOXYLIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; FEMALE; GAMMA-AMINOBUTYRIC ACID; HEART RATE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; POLYSOMNOGRAPHY; PROLACTIN; PSYCHOMOTOR PERFORMANCE; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 77951082140     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNF.0b013e3181cda242     Document Type: Article

References (48)

1. Liappas IA, Malitas PN, Dimopoulos NP, et al. Zolpidem dependence case series: possible neurobiological mechanisms and clinical management. J Psychopharmacol 2003;17:131-135.
2. Elliot EE, White JM. The acute effects of zolpidem compared to diazepam and lorazepam using radiotelemetry. Neuropharmacology 2001;40:717-721.
3. Toner LC, Tsambiras BM, Catalano G, et al. Central nervous system side effects associated with zolpidem treatment. Clin Neuropharmacol 2000;23(1):54-58.
4. Mintzer MZ, Griffiths RR. Selective effects of zolpidem on human memory functions. J Psychopharmacol 1999;13:18-31.
5. Gordh TE, Stubhaug A, Jensen TS, et al. Gabapentin in traumatic nerve injury pain: a randomized, double-blind, placebo-controlled, cross-over, multi-center study. Pain 2008;138:255-266.
6. Tanabe M, Takasu K, Takeuchi Y, et al. Pain relief by gabapentin and pregabalin via supraspinal mechanisms after peripheral nerve injury. J Neurosci Res 2008;86:3258-3264.
7. Gray P. Acute neuropathic pain: diagnosis and treatment. Curr Opin Anaesthesiol 2008;21:590-595.
8. Tzellos TG, Papazisis G, Amaniti E, et al. Efficacy of pregabalin and gabapentin for neuropathic pain in spinal-cord injury: an evidence-based evaluation of the literature. Eur J Clin Pharmacol 2008;64:851-858.
9. Satija P, Ondo WG. Restless legs syndrome: pathophysiology, diagnosis and treatment. CNS Drugs 2008;22:497-518.
10. Mellick GA, Mellick LB. Management of restless legs syndrome with gabapentin (Neurontin). Sleep 1996;19:224-226.
11. Garcia-Borreguero D, Larrosa O, de la Llave Y, et al. Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study. Neurology 2002;59:1573-1579.
12. Happe S, Klosch G, Saletu B, et al. Treatment of idiopathic restless legs syndrome (RLS) with gabapentin. Neurology 2001;57:1717-1719.
13. Wilton LV, Shakir S. A postmarketing surveillance study of gabapentin as add-on therapy for 3100 patients in England. Epilepsia 2002;43:983-992. (Pubitemid 35006473)
14. Rao ML, Clarenbach P, Vahlensieck M, et al. Gabapentin augments whole blood serotonin in healthy young men. J Neural Transm 1988;73:129-134.
15. Foldvary-Schaefer N, De Leon Sanchez I, Karafa M, et al. Gabapentin increases slow-wave sleep in normal adults. Epilepsia 2002;43:1493-1497.
16. Rosenberg KP. Gabapentin for chronic insomnia. Am J Addict 2003;12:273-274.
17. Vollmer KO, Anhut H, Thomann O, et al. Pharmacokinetic model and absolute bioavailability of the new anticonvulsant gabapentin. Adv Epileptol 1989;17:209-211.
18. Iber C, Ancoli-Israel S, Chesson AL Jr, et al. The AASM Manual for the Scoring of Sleep and Associated Events. Westchester, IL: American Academy of Sleep Medicine; 2007.
19. Zucconi M, Ferri R, Allen R, et al. The official World Association of Sleep Medicine (WASM) standards for recording and scoring periodic leg movements in sleep (PLMS) and wakefulness (PLMW) developed in collaboration with a task force from the International Restless Legs Syndrome Study Group (IRLSSG). Sleep Med 2006;7:175-218.
20. Werth E, Achermann P, Borbely AA. Fronto-occipital EEG gradients in human sleep. J Sleep Res 1997;6:102-112.
21. Task Force of the European Society of Cardiology and North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation 1996;93:1043-1065.
22. Buysse DJ, Reynolds CF 3rd, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193-213.
23. Joy S, Kaplan E, Fein D. Speed and memory in the WAIS-III digit symbolYcoding subtest across the adult lifespan. Arch Clin Neuropsychol 2004;19:759-767.
24. Kreiner DS, Ryan JJ. Memory and motor skill components of the WAIS-III digit symbolYcoding subtest. Clin Neuropsychol 2001;15:109-113.
25. Tulsky DS, Saklofske DH, Chelune GJ, et al. Clinical Interpretation of the WAIS-III and WMS-III. San Diego, CA: Academic Press; 2003.
26. Lichtenberger EO, Kaufman AS, Lai ZC. Essentials of WMS-III Assessment (Essentials of Psychological Assessment). Hoboken, NJ: Wiley; 2001.
27. Uttl B, Graf P. Color-word Stroop test performance across the adult life span. J Clin Exp Neuropsychol 1997;19:405-420.
28. Lu PH, Boone KB, Jimenez N, et al. Failure to inhibit the reading response on the Stroop test: a pathognomonic indicator of suspect effort. J Clin Exp Neuropsychol 2004;26:180-189.
29. Czapinski P, Blaszczyk B, Czuczwar SJ. Mechanisms of action of antiepileptic drugs. Curr Top Med Chem 2005;5:3-14.
30. Ehrenberg B. Importance of sleep restoration in co-morbid disease: effect of anticonvulsants. Neurology 2000;54(5 suppl 1):S33-S37. (Pubitemid 30151837)
31. Karam-Hage M, Brower KJ. Gabapentin treatment for insomnia associated with alcohol dependence [comment]. Am J Psychiatry 2000;157:151.
32. Bazil CW, Battista J, Basner RC. Gabapentin improves sleep in the presence of alcohol. J Clin Sleep Med 2005;1:284-287.
33. Cote KA, Epps TM, campbell KB. The role of the spindle in human information processing of high-intensity stimuli during sleep. J Sleep Res 2000;9:19-26.
34. Sato Y, Fukuoka Y, Minamitani H, et al. Sensory stimulation triggers spindles during sleep stage 2. Sleep 2007;30:511-518.
35. Burr RL. Interpretation of normalized spectral heart rate variability indices in sleep research: a critical review. Sleep 2007;30:913-919.
36. Spiegel K, Luthringer R, Follenius M, et al. Temporal relationship between prolactin secretion and slow-wave electroencephalic activity during sleep. Sleep 1995;18:543-548.
37. Roky R, Obal F Jr, Valatx JL, et al. Prolactin and rapid eye movement sleep regulation. Sleep 1995;18:536-542.
38. Copinschi G, Van Onderbergen A, L'Hermite-Baleriaux M, et al. Effects of the short-acting benzodiazepine triazolam, taken at bedtime, on circadian and sleep-related hormonal profiles in normal men. Sleep 1990;13:232-244.
39. Copinschi G, Akseki E, Moreno-Reyes R, et al. Effects of bedtime administration of zolpidem on circadian and sleep-related hormonal profiles in normal women. Sleep 1995;18:417-424.
40. Ferrara M, De Gennaro L. The sleep inertia phenomenon during the sleep-wake transition: theoretical and operational issues. Aviat Space Environ Med 2000;71:843-848.
41. Ferrara M, Curcio G, Fratello F, et al. The electroencephalographic substratum of the awakening. Behav Brain Res 2006;167:237-244.
42. Meador K, Loring D, Gallagher B et al. Comparative cognitive effects of anticonvulsants. Neurology 1990;40:391-394.
43. Aldenkamp A. Effects of antiepileptic drugs on cognition. Epilepsia 2001;42(suppl 1):46-49.
44. Meador K, Gilliam F, Kanner A, et al. Cognitive and behavioral effects of antiepileptic drugs. Epilepsy Behav 2001;4:SS1-SS17. (Pubitemid 33653385)
45. Salinsky MC, Storzbach D, Spencer DC, et al. Effects of topiramate and gabapentin on cognitive abilities in healthy volunteers. Neurology 2005;64:792-798.
46. Marin R, Kuzniecky R, Ho S, et al. Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults. Neurology 1999;52:321-327.
47. Hunter P. To sleep, perchance to live. Sleeping is vital for health, cognitive function, memory and long life. EMBO Rep 2008;9:1070-1073.
48. Fulda S, Shulz H. Cognitive dysfunction in sleep disorders. Sleep Med Rev 2001;5:423-445